Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally.
Aytu Biopharma stock last closed at $1.95, up 0% from the previous day, and has decreased 32.06% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.03 percentage points. Aytu Biopharma stock is currently +105.26% from its 52-week low of $0.95, and -34.78% from its 52-week high of $2.99.
At the moment, there are 6.17M shares of AYTU outstanding. The market value of AYTU is $12.03M. In the last 24 hours, 94,000 AYTU shares were traded.
You need a brokerage account to access the NASDAQ market and buy AYTU shares.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in AYTU stock today.
Now that you've filled out your info on one of the best stock market apps, you need to deposit funds:
Watch the video below if you need help transferring funds into your new investment account.
After you have selected the best place to buy Aytu Biopharma stock, it's absolutely critical to evaluate their stock prior to buying, so you actually understand the risk and upside.
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on AYTU's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AYTU's intrinsic value.
Using relative valuations ratios:
You can do more valuation analysis on AYTU's stock here.
Last year, AYTU revenue was $69.22M. During the past 5 year, AYTU's revenue has gone up by 36.73% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 9.6%.
Dig into AYTU's earnings and revenue performance here.
In the last 12 months, insiders at AYTU have bought more shares than they have sold.
Jarrett Disbrow, Chief Business Officer of AYTU, was the latest AYTU insider to buy. They bought $24,999.00 worth of AYTU stock on Jun 9, 2025.
Dig into more about who owns AYTU stock here.
No, Aytu Biopharma doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary options:
Press the Open Trade button and eToro will execute the order.
If you require more help with buying stocks on eToro, click the helpful video below:
Now that you own some AYTU shares, you'll want to keep up with your new stock purchase.
Add AYTU to a watchlist to keep tabs on your AYTU stock.
To summarize, here are the 6 steps to buy stock in Aytu Biopharma:
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Aytu Biopharma, click the button below.